IL-33 induces functional CCR7 expression in human mast cells - 05/10/18
Doi : 10.1016/j.jaci.2018.06.007
Maiko Emi-Sugie, PhD a, Sumika Toyama, PhD a, b, Akio Matsuda, PhD a, Hirohisa Saito, MD, PhD a, Kenji Matsumoto, MD, PhD a 
a Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
b Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
| This work was supported in part by grants from the National Institute of Biomedical Innovation (grant no. ID10-43 to K.M.) and from the National Center for Child Health and Development (grant no. 26-46 to M.E.-S. and grant no. 26-9 to K.M.). |
|
| Disclosure of potential conflict of interest: M. Emi-Sugie reports a grant (grant no. 26-46) from the National Center for Child Health and Development. H. Saito reports payment for lectures including service on speakers' bureaus from Shiseido Co, Ltd and AstraZeneca. K. Matsumoto reports payment for lectures including service on speakers bureaus from MSD (Merck Sharp and Dohme) K.K., Kyorin Pharmaceutical Co, Ltd, AstraZeneca K.K., Maruho Co, Ltd, Teijin Pharma Ltd, and Chugai Pharmaceutical Co, Ltd; employment with the National Research Institute for Child Health and Development; grants from the National Institute of Biomedical Innovation (grant no. ID10-43) and the National Center for Child Health and Development (grant no. 26-9). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 4
P. 1341-1344 - octobre 2018 Retour au numéro
Article précédent
- Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial
- Laila Hellkvist, Eric Hjalmarsson, Susanna Kumlien Georén, Agneta Karlsson, Karin Lundkvist, Ola Winqvist, Ulla Westin, Lars Olaf Cardell
- Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2
- Guillaume Churlaud, Chadi Abbara, Pierre-Axel Vinot, Gwladys Fourcade, Paul-Gydeon Ritvo, Roberta Lorenzon, Michelle Rosenzwajg, Bertrand Diquet, David Klatzmann
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?